14 items
2026-04-28
Mitsubishi Research Institute, Inc., ¥ 85.0, Cash Dividend, Sep-29-2026
2026-03-09
Meiji Yasuda Life Insurance Company and Mitsubishi UFJ Trust and Banking Corporation agreed to acquire an additional 70.10% stake in Global Alliance Realty Co.,Ltd. from Kintetsu Group Holdings Co.,Ltd. (TSE:9041), MUFG Bank, Ltd., Kintetsu Insurance Service Co., Ltd., Mitsubishi HC Capital Inc. (TSE:8593), Mitsubishi Research Institute, Inc. (TSE:3636), Diamond Sports Club Inc and others on March 6, 2026. Upon completion, Meiji Yasuda Life Insurance Company will own 42.55% and Mitsubishi UFJ Trust and Banking Corporation will own 42.55% stake in Global Alliance Realty Co.,Ltd. The transaction is subject to approval of merger agreement by target board, approval of relevant authorities and other general conditions. The expected completion of the transaction is March 31, 2026.
2026-03-06
Mitsubishi Research Institute, Inc., Q2 2026 Earnings Call, Apr 28, 2026
2026-01-07
Mitsubishi Research Institute, Inc., ¥ 80.0, Cash Dividend, Mar-30-2026
2025-12-24
Mitsubishi Research Institute, Inc. announced that they will report Q2, 2026 results on Apr 27, 2026
2025-12-24
Mitsubishi Research Institute, Inc. announced that they will report Q3, 2026 results on Jul 29, 2026
2025-12-24
Mitsubishi Research Institute, Inc. announced that they will report Q1, 2026 results on Feb 05, 2026
2025-11-03
Mitsubishi Research Institute, Inc. at a meeting of its Board of Directors held on October 30, 2025, resolved to propose amendments to its Articles of Association at the 56th Annual General Meeting of Shareholders scheduled for December 17, 2025. MRI has made the necessary changes to its Articles of Association to establish an optimal and flexible management structure and to clearly state that the president, who is the chief executive responsible for the execution of business, is an executive officer. The amendments include changes to Article 15 regarding the convocation and chairperson of the general meeting of shareholders, Article 22 regarding the election of representative director and chairman of the Board, and Article 31 regarding the election of executive officers and research fellows. The effective date of the amended Articles of Association is December 17, 2025.
2025-11-03
Mitsubishi Research Institute, Inc. provided consolidated earnings guidance for the year ending September 30, 2026. For the period, the company forecast net sales of JPY 122,000 million, net profit of JPY 7,500 million, Profit attributable to owners of parent of JPY 5,800 million, and Basic earnings per share JPY 368.26.
2025-11-03
Mitsubishi Research Institute, Inc. provided dividend guidance for the second quarter end and year end of fiscal year ending September 30, 2026. for the second quarter end, the company expects dividend of JPY 80.00 per share against JPY 80.00 per share a year ago. for the year end, the company expects dividend of JPY 85.00 per share against JPY 85.00 per share a year ago.
2025-11-03
Mitsubishi Research Institute, Inc. declared dividend of JPY 85.00 per share for the year ended September 30, 2025 against JPY 80.00 per share a year ago. Scheduled date to commence dividend payments is December 18, 2025.
2025-10-31
Mitsubishi Research Institute, Inc., Board Meeting, Oct 30, 2025. Agenda: To consider and approve to propose amendments to its Articles of Association at the 56th Annual General Meeting.
2025-10-30
Mitsubishi Research Institute, Inc., Annual General Meeting, Dec 17, 2025, at 10:00 Tokyo Standard Time. Location: 4th floor Conference Room at the Head Office of the Company 10-3 Nagatacho 2-Chome, Chiyoda-Ku Tokyo Japan Agenda: To consider the business report for the fiscal year ended September 30, 2025, including consolidated and non-consolidated financial statements, and the results of the audit of the consolidated financial statements by the accounting auditor and the audit & supervisory board; to consider appropriation of surplus; to consider amendment to the articles of association; to consider election of eight directors; and to consider election of one audit & supervisory board member.
2025-10-30
Mitsubishi Research Institute, Inc. expected to report Q1 2026 results on February 4, 2026. This event was calculated by S&P Global (Created on November 27, 2025).
2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 128,067 | 128,592 | 124,651 | 121,458 | 116,731 | 114,265 | 115,400 | 115,362 | 115,502 | 115,335 |
Pretax Income Excl.Unusual Items | 10,173 | 12,186 | 11,652 | 9,733 | 8,261 | 6,446 | 7,648 | 8,146 | 8,622 | 9,506 |
Total Assets | 129,104 | 140,413 | 124,187 | 128,113 | 122,956 | 128,274 | 117,900 | 119,732 | 120,220 | 130,392 |
Total Liabilities | 42,724 | 51,861 | 41,536 | 46,768 | 43,680 | 47,869 | 41,742 | 43,360 | 43,774 | 51,103 |
Cash & Cash Equivalents | 29,923 | 15,673 | 20,407 | 30,310 | 34,594 | 15,421 | 21,308 | 30,927 | 35,235 | 10,766 |
Total Common Equity | 77,222 | 79,208 | 73,322 | 71,923 | 70,340 | 71,458 | 67,380 | 67,630 | 67,744 | 70,443 |
Book Value Per Share (BVPS) | 4,900.07 | 5,026.09 | 4,654.55 | 4,566.59 | 4,466.07 | 4,537.05 | 4,279.75 | 4,296.47 | 4,303.76 | 4,475.23 |
Net Change in Cash | 752 | -617 | 4,654 | 5,700 | -3,177 | |||||
Capital Expenditure | -3,882 | -3,615 | -1,147 | -1,357 | -2,607 |
As of July 29, 2026, Mitsubishi Research Institute published financial results for the second quarter of 2026, with revenues of 25.66B yen and net loss of -1.59B yen, indicating a decline of 2% in revenue, with a shift from a profit per share in the same quarter last year to a loss per share in the current quarter. A negative note is that this latest revenue figure disrupts a sequence of 2th consecutive quarters in which the company has shown growth compared to last year's corresponding quarter. This could provide insight into a potential weakness of the company and whether it is capable of continuing to grow in the future.
and it trades at 9.2x times current year's earnings, which is lower than the sector average (P/E 10.8x).